The 'official' and only endpoint of the P1b is no dose limiting toxicities. They don't have to report on any ancillary FTO assessment that is being undertaken as part of the biomarker collaboration with Sheba. Not until they have the sufficient commercial protection.
- Forums
- ASX - By Stock
- RAC
- RAC media coverage
RAC media coverage, page-881
-
-
- There are more pages in this discussion • 1,416 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.58 |
Change
0.040(2.60%) |
Mkt cap ! $269.2M |
Open | High | Low | Value | Volume |
$1.60 | $1.60 | $1.55 | $150.3K | 96.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 81 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 2472 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 81 | 1.580 |
2 | 5635 | 1.575 |
2 | 16186 | 1.570 |
2 | 10056 | 1.560 |
3 | 34981 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.590 | 2472 | 1 |
1.600 | 12088 | 2 |
1.620 | 2000 | 1 |
1.650 | 7731 | 1 |
1.685 | 5000 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online